Cigna received its final approval from regulators for its $67 billion acquisition of Express Scripts. New Jersey approved the transaction, clearing the way for the deal to close, according to a public filing from Cigna.
“All required regulatory approvals now have been received and the parties expect to close the transaction on December 20, 2018, subject to the satisfaction of all other closing conditions,” the filing reads.
The transaction brings together a major health insurance provider with one of the nation’s largest pharmacy benefit managers. California and New York approved the deal on Dec. 13, but New Jersey remained as the last holdout.
The completion of the merger was originally anticipated to close by Dec. 8, but Cigna executives signaled the deal would be delayed in late November.
Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."